Keywords: roche, buy, nimblegen, 5m, swiss, drug, major
Roche to buy NimbleGen for $272.5M
Article | 25 June 2007
Swiss drug major Roche has signed a definitive agreement to acquire 100% of NimbleGen, a privately-held, Madison, Wisconsin, USA-based company active ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
